Literature DB >> 23892043

Impact of psychological screening on routine outpatient care of hematopoietic cell transplantation survivors.

Flora Hoodin1, Lili Zhao, Jillian Carey, John E Levine, Carrie Kitko.   

Abstract

Hematopoietic cell transplantation recipients are at high risk for psychological distress, with reported prevalence rates as high as 40%. Although published guidelines advocate periodic routine screening, it is unclear how screening affects management of psychological symptoms at routine post-HCT outpatient clinic visits. We hypothesized that providers will be more likely to act on patients' psychological symptoms if a screening survey is completed and reviewed before a clinic visit. We used a brief, diagnostically focused Patient Health Questionnaire (PHQ), to assess for depressive disorders, anxiety, substance abuse, and problems in occupational or interpersonal functioning (functional disruption). Adult HCT survivors were randomized to complete the PHQ before meeting with their medical provider (n = 50; experimental group) or afterwards (n = 51; control group). Providers used the experimental group PHQ results at their discretion during the visits. Both providers and patients rated their satisfaction with management of psychological concerns after the visit. The prevalence of clinically significant depression (21%), anxiety (14%), or suicidal ideation (8%) did not differ between the 2 groups. Patients in the experimental group were significantly more likely to have discussion of psychological symptoms than the control group (68% versus 49%, P = .05). Medical providers were significantly more satisfied with the management of psychological issues for the experimental group (P < .001). Patients with depression or anxiety were significantly more likely to prefer the PHQ be used at future visits (P = .02 and P = .001, respectively). These findings suggest an informative yet brief self-report psychological screen can be easily integrated into routine care of hematopoietic cell transplantation survivors, stimulates discussion of psychological symptoms, and improves provider satisfaction with psychological symptom management. Future research will evaluate whether serial prospective administration improves patient outcomes.
Copyright © 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer survivorship; Depression; Hematopoietic stem cell transplantation; Psychological; Screening

Mesh:

Year:  2013        PMID: 23892043      PMCID: PMC5605293          DOI: 10.1016/j.bbmt.2013.07.019

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  15 in total

1.  Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year?

Authors:  M Hjermstad; H Holte; S Evensen; P Fayers; S Kaasa
Journal:  Bone Marrow Transplant       Date:  1999-10       Impact factor: 5.483

2.  Oncologists' recognition of depression in their patients with cancer.

Authors:  S D Passik; W Dugan; M V McDonald; B Rosenfeld; D E Theobald; S Edgerton
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

3.  Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation.

Authors:  Jesús M Prieto; Jorge Atala; Jordi Blanch; Enric Carreras; Montserrat Rovira; Esteve Cirera; Anna Espinal; Cristóbal Gasto
Journal:  J Clin Oncol       Date:  2005-08-08       Impact factor: 44.544

4.  Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation.

Authors:  Jesús M Prieto; Jordi Blanch; Jorge Atala; Enric Carreras; Montserrat Rovira; Esteve Cirera; Cristóbal Gastó
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

6.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

7.  Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams; Patrick O Monahan; Bernd Löwe
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

8.  Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003.

Authors:  Ronald C Kessler; Patricia Berglund; Guilherme Borges; Matthew Nock; Philip S Wang
Journal:  JAMA       Date:  2005-05-25       Impact factor: 56.272

9.  Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer.

Authors:  Jesse R Fann; Donna L Berry; Seth Wolpin; Mary Austin-Seymour; Nigel Bush; Barbara Halpenny; William B Lober; Ruth McCorkle
Journal:  Psychooncology       Date:  2009-01       Impact factor: 3.894

10.  Psychological distress in long-term survivors of hematopoietic stem cell transplantation.

Authors:  Anna Rusiewicz; Katherine N DuHamel; Jack Burkhalter; Jamie Ostroff; Gary Winkel; Eileen Scigliano; Esperanza Papadopoulos; Craig Moskowitz; William Redd
Journal:  Psychooncology       Date:  2008-04       Impact factor: 3.894

View more
  10 in total

1.  Risk factors for depression in patients undergoing hematopoietic cell transplantation.

Authors:  Samantha B Artherholt; Fangxin Hong; Donna L Berry; Jesse R Fann
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-18       Impact factor: 5.742

Review 2.  Palliative care during and following allogeneic hematopoietic stem cell transplantation.

Authors:  Sandra A Mitchell
Journal:  Curr Opin Support Palliat Care       Date:  2018-03       Impact factor: 2.302

Review 3.  Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.

Authors:  Minoo Battiwalla; André Tichelli; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2016-11-03       Impact factor: 5.742

4.  High prevalence of distress in patients after allogeneic hematopoietic SCT: fear of progression is associated with a younger age.

Authors:  J Hefner; M Kapp; K Drebinger; A Dannenmann; H Einsele; G-U Grigoleit; H Faller; H Csef; S Mielke
Journal:  Bone Marrow Transplant       Date:  2014-01-20       Impact factor: 5.483

5.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Authors:  Paul A Carpenter; Carrie L Kitko; Sharon Elad; Mary E D Flowers; Juan C Gea-Banacloche; Jörg P Halter; Flora Hoodin; Laura Johnston; Anita Lawitschka; George B McDonald; Anthony W Opipari; Bipin N Savani; Kirk R Schultz; Sean R Smith; Karen L Syrjala; Nathaniel Treister; Georgia B Vogelsang; Kirsten M Williams; Steven Z Pavletic; Paul J Martin; Stephanie J Lee; Daniel R Couriel
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-31       Impact factor: 5.742

Review 6.  Anxiety and Depression in Cancer Survivors.

Authors:  Jean C Yi; Karen L Syrjala
Journal:  Med Clin North Am       Date:  2017-08-18       Impact factor: 5.456

Review 7.  Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant.

Authors:  Anna Barata; William A Wood; Sung Won Choi; Heather S L Jim
Journal:  Curr Hematol Malig Rep       Date:  2016-08       Impact factor: 3.952

8.  Routine depression screening in an MS clinic and its association with provider treatment recommendations and related treatment outcome.

Authors:  L M Stepleman; L M Penwell-Waines; M Rollock; R S Casillas; T Brands; J Campbell; B Ange; J L Waller
Journal:  J Clin Psychol Med Settings       Date:  2014-12

9.  A randomized clinical trial on the effectiveness of an intervention to treat psychological distress and improve quality of life after autologous stem cell transplantation.

Authors:  Annemarie M J Braamse; B van Meijel; O J Visser; A D Boenink; P Cuijpers; C E Eeltink; A W Hoogendoorn; M van Marwijk Kooy; P van Oppen; P C Huijgens; A T F Beekman; J Dekker
Journal:  Ann Hematol       Date:  2015-09-30       Impact factor: 3.673

10.  Quality of Life and Psychopathology in Adults Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) in Childhood: A Qualitative and Quantitative Analysis.

Authors:  Francesco Sinatora; Annalisa Traverso; Silvia Zanato; Nicoletta Di Florio; Alessio Porreca; Marta Tremolada; Valentina Boscolo; Antonio Marzollo; Chiara Mainardi; Elisabetta Calore; Marta Pillon; Chiara Cattelan; Giuseppe Basso; Chiara Messina
Journal:  Front Psychol       Date:  2017-08-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.